| Financial Year |
March 31 2023 |
| Monetary Funds |
1,830,728,351.61 |
| Held-for-trading Financial Assets |
584,095,052.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,213,028,205.07 |
| Advances to Suppliers |
21,746,129.76 |
| Other Receivables |
1,699,280.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,221,048,233.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,862,441.91 |
| Total Current Assets |
4,935,472,684.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,977,471,834.48 |
| Under-construction Projects |
1,137,645,161.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
503,549,869.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,321,101.65 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
96,325,750.66 |
| Sub-Total of Non-Current Assets |
4,716,313,718.30 |
| Total Assets |
9,651,786,402.60 |
| Short-Term Loans |
1,063,820,711.36 |
| Trading Financial liabilities |
1,338,525.27 |
| Notes Payable |
898,656,144.34 |
| Accounts Payable |
728,669,364.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
78,094,763.32 |
| Taxes Payable |
34,365,081.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,960,045.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
563,888.89 |
| Other Current Liabilities |
8,001,308.50 |
| Sub-Total of Current Liabilities |
2,898,362,912.86 |
| Long-term Loans |
700,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
92,134,252.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
933,390,101.21 |
| Total Liabilities |
3,831,753,014.07 |
| Paid-In Capital(Or Share Stock) |
666,582,095.00 |
| Capital Surplus |
2,960,956,757.33 |
| Surplus Reserve |
244,573,676.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,898,348,747.24 |
| Minority Stockholder's Interest |
11,951,847.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,808,081,540.88 |
| Owner's Equity（Stockholder's Equity） |
5,820,033,388.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,651,786,402.60 |
